Translational Development Acquisition Corp.
NASDAQ:TDACShell Companies
-$0.01 today
- Market cap
- $267.99M
- Beta
- 0.01
- P/E (TTM)
- 29.8
- EPS (TTM)
- $0.36
Volume 0.47M
Average 0.10M
TDAC Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Translational Development Acquisition Corp.NASDAQ: TDAC
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock rises 4.0% from a year ago
Common stock stood at $183.27M at the end of Q1 FY2026, up 4.0% from a year earlier and up 0.9% from the prior quarter. Over 3 fiscal years it compounded at +7205.0% a year.
Context
- Common stock amounted to 100.0% of total assets at the end of Q1 FY2026, up 0.2 pp from a year earlier.
- Common stock increased in 1 of the last 3 fiscal years.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +4.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 181.66M USD
- Year-over-year change
- -99.0%
- 3-year CAGR
- +7205.0%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 181.66M | -99.0% |
| FY2024 | 2024-12-31 | 18.33B | +3932832518.0% |
| FY2023 | 2023-12-31 | 466 | +0.0% |
| FY2022 | 2022-12-31 | 466 | — |
Common Stock vs competitors
How TDAC compares with its peers on the latest reported figures
- TDAC's Mar 2026 common stock of $183.27M is the 5th highest of the 7 companies compared; the peer median is $184.39M.
- Its year-over-year change of +4.0% is the 4th highest of 6, against a peer median of +4.1%.
- Common stock amounts to 100.0% of total assets for TDAC, versus a peer median of 99.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $239.05M | +31166243.5% | +14.1% | 99.7% | |
| Mar 2026 | $212.37M | +38613481.5% | +7395.0% | 101.3% | |
| Mar 2026 | $185.33M | +3.9% | -19.3% | 99.7% | |
NTWONewbury Street II Acquisition Corp | Mar 2026 | $183.45M | +4.0% | — | 99.6% |
| Mar 2026 | $183.27M | +4.0% | +7205.0% | 100.0% | |
MACIMelar Acquisition Corp. I | Mar 2026 | $172.92M | +4.1% | — | 97.7% |
| Jun 2025 | $844 | — | — | 0.2% | |
| Peer median (excluding TDAC) | $184.39M | +4.1% | +14.1% | 99.7% | |
Competitors are the stored peer set for TDAC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Translational Development Acquisition Corp.
NASDAQ:TDAC
Intrinsic Alpha fair value
Locked
Current Price
$10.88
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.